Tumor-associated Macrophages in Breast Cancer: Potential Therapeutic Strategies and Future Prospects
DOI:
https://doi.org/10.61173/bg0c7d34Keywords:
Tumor-associated macrophages, Tumor microenvironment, Target therapy, Breast can-cerAbstract
Among women, breast cancer (BC) ranks as one of the most prevalent malignant tumors and is the primary cause of mortality from cancer. Circulating monocytes and embryonic tissue-resident cells give rise to tumor-associated macrophages (TAMs). TAM represents the major immune cell population in the breast tumor microenvironment and are closely associated with BC onset, progression and metastasis. This review highlights that TAM cells are classified into M1 and M2 types, and the two subtypes can be transformed into each other under certain conditions with a high degree of plasticity. TAM can contribute to BC growth by promoting the growth of cancer cells, facilitating tumor immune escape and enhancing cancer drug resistance. In addition, this review emphasized that immune resistance in BC can be overcome by inhibiting TAM recruitment, reprogramming TAM, removing existing TAM and blocking the immunosuppressive function of TAM. In the future, the combination of TAM and immune checkpoint inhibitors will become the mainstream direction for improving the survival cycle of patients with advanced breast cancer.
References
[1] Huang, X., Cao, J., & Zu, X. (2022). Tumor-associated macrophages: An important player in breast cancer progression. Thoracic cancer, 13(3), 269–276. https://doi.org/10.1111/1759- 7714.14268
[2] Yang, Y., Li, S., To, K. K. W., Zhu, S., Wang, F., & Fu, L. (2025). Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy. Journal of Experimental & Clinical Cancer Research, 44(1), 145. https://doi.org/10.1186/s13046-025- 03377-9
[3] Munir, M. T., Kay, M. K., Kang, M. H., Rahman, M. M., Al- Harrasi, A., Choudhury, M., Moustaid-Moussa, N., Hussain, F., & Rahman, S. M. (2021). Tumor-Associated Macrophages as Multifaceted Regulators of Breast Tumor Growth. International journal of molecular sciences, 22(12), 6526. https://doi. org/10.3390/ijms22126526
[4] Saeed, A. F. (2025). Tumor-Associated Macrophages: Polarization, Immunoregulation, and Immunotherapy. Cells, 14(10), 741. https://doi.org/10.3390/cells14100741
[5] Jin, H., Meng, X. Y., & Feng, J. W. (2025). Mechanisms of tumor-associated macrophages in breast cancer and treatment strategy. Frontiers in Immunology, 16, 1560393. https://doi. org/10.3389/fimmu.2025.1560393
[6] Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand- Rosenberg, S., Hedrick, C. C., Vonderheide, R. H., Pittet, M. J., Jain, R. K., Zou, W., Howcroft, T. K., Woodhouse, E. C., Weinberg, R. A., & Krummel, M. F. (2018). Understanding the tumor immune microenvironment (TIME) for effective therapy. Nature medicine, 24(5), 541–550. https://doi.org/10.1038/ s41591-018-0014-x
[7] Ren, B., Cui, M., Yang, G., Wang, H., Feng, M., You, L., & Zhao, Y. (2018). Tumor microenvironment participates in metastasis of pancreatic cancer. Molecular cancer, 17(1), 108. https://doi.org/10.1186/s12943-018-0858-1
[8] Nagarsheth, N., Wicha, M. S., & Zou, W. (2017). Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nature reviews. Immunology, 17(9), 559–572. https://doi.org/10.1038/nri.2017.49
[9] DeNardo, D. G., & Ruffell, B. (2019). Macrophages as regulators of tumour immunity and immunotherapy. Nature reviews. Immunology, 19(6), 369–382. https://doi.org/10.1038/ s41577-019-0127-6
[10] Kundu, M., Butti, R., Panda, V. K., Malhotra, D., Das, S., Mitra, T., Kapse, P., Gosavi, S. W., & Kundu, G. C. (2024). Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer. Molecular cancer, 23(1), 92. https://doi.org/10.1186/s12943-024- 01990-4
[11] Rumney, R. M. H., Coffelt, S. B., Neale, T. A., Dhayade, S., Tozer, G. M., & Miller, G. (2017). PyMT-Maclow: A novel, inducible, murine model for determining the role of CD68 positive cells in breast tumor development. PloS one, 12(12), e0188591. https://doi.org/10.1371/journal.pone.0188591
Downloads
Published
Issue
Section
License
Copyright (c) 2025 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
